Tsuyoshi Kondo

Is 2‐Propyl‐4‐Pentenoic Acid, a Hepatotoxic Metabolite of Valproate, Responsible for Valproate‐Induced Hyperammonemia?

Tsuyoshi Kondo, Masayuki Ishida, Sunao Kaneko et al. · Epilepsia · 1992 · 28 citations

Adverse Effects of Zotepine and Their Relationship To Serum Concentrations of the Drug and Prolactin

Tsuyoshi Kondo, Koichi Otani, Masayuki Ishida et al. · Therapeutic Drug Monitoring · 1994 · 23 citations

Psychopharmacology, Neuropsychiatry, Pharmacotherapy +18

Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients

Akihito Suzuki, Tsuyoshi Kondo, Kazuo Mihara et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2000 · 16 citations

Psychiatry, Psychotic Disorder, Psychiatric Genetics +11

Teratogenicity of Antiepileptic Drugs and Drug Specific Malformations

Sunao Kaneko, Koichi Otani, Tsuyoshi Kondo et al. · Psychiatry and Clinical Neurosciences · 1993 · 15 citations

Antiepileptic Drugs, Medicine, Neuropharmacology +3

Characteristics and Risk Factors of Acute Dystonia in Schizophrenic Patients Treated With Nemonapride, a Selective Dopamine Antagonist

Tsuyoshi Kondo, Koichi Otani, Noboru Tokinaga et al. · Journal of Clinical Psychopharmacology · 1999 · 11 citations